GeneDx任命Linda Genen博士为CMO

2026-01-06 21:48

GeneDx (NASDAQ:WGS) on Tuesday stated the appointment of Linda Genen, MD, MPH, as Chief Medical Officer.
Genen brings decades of leadership across clinical care, payer strategy, innovation, and maternal-infant health, joining the company from ProgenyHealth, where she served as CMO following a career as a neonatologist and healthcare executive.
At UnitedHealth Group and Optum, Genen served in senior leadership roles, driving the development and scaling of innovative care models in women’s health, digital health, and maternal-infant medicine.
Presently, she is a board member at Hera Women’s Health and a distinguished mentor in Stanford University’s Clinical Informatics management program.

More on GeneDx Holdings Corp.